Vendor, Edina, MN
Humanetics Corporation
UEI MSRQYLLQLYQ5, CAGE 4B2E0
1 award and $0 obligated between April 15, 2024 and March 3, 2025, 100% under full and open competition, against 12.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSN272201800011CDefinitive Contract, April 15, 2024, Full and Open Competition, 12 offers | National Institutes of Health NiaidNational Institutes of Health | Igf an NHP Efficacy Study of Bio 300 for Mitigator for Deare-Induced Pneumonitis and Pulmonary FibrosisNAICS 541713, PSC AN13 | $0 |
- Places of performance
- Minnesota
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 2 across 1 awards